What You Should Know:
– GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner.
– This system offers new capabilities for both clinical imaging and…
Continue Reading
What You Should Know:
– Helix, a leader in population genomics and precision health, presented groundbreaking research at the American Society of Human Genetics (ASHG) 2024 Annual Meeting.
– The highlight was a novel AI-powered model…
Continue Reading
The development of new drugs or medical interventions is a meticulous process involving various stages to ensure safety, efficacy, and regulatory compliance. Central to this journey are the preclinical and clinical trial phases, which…
Continue Reading
Global healthcare AI company Ubie announced its AI-enabled symptom tracker will be integrated into PatientsLikeMe’s patient engagement and health management platform to support patients from the first sign of symptoms through the treatment journey. Ubie…
Continue Reading
It’s not an easy question to answer, but with a well thought out roadmap, it’s doable.
By John Halamka, M.D., President, Mayo Clinic Platform and Paul Cerrato, MA, senior research analyst and communications specialist, Mayo…
Continue Reading
What You Should Know:
– Medeloop, a pioneering medical research platform, has secured $15.5M in Series A funding to further its mission of revolutionizing medical research through artificial intelligence (AI).
– The funding round was led…
Continue Reading
Taylor Wirth, Partner at Barnes & Thornburg
Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they pursue an initial public offering (IPO) to fuel their growth,…
Continue Reading
What You Should Know:
– Bluespine, an AI-driven claims cost reduction platform for self-insured employers, has secured $7.2M in seed funding to address the pervasive issue of medical overbilling in the US healthcare system led…
Continue Reading
The post–acute care space requires continual evolvement as technology expands to address care setting needs and regulatory changes. In 2022, we published a blog that explored KLAS’ research with post–acute care at the time—since,…
Continue Reading
Former President Donald Trump’s return to the White House is certain to bring about changes across many facets of the healthcare sector — including reproductive care, federal insurance programs and prescription drugs.
Experts interviewed for…
Continue Reading
